Go to content
UR Home

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

URN to cite this document:
urn:nbn:de:bvb:355-epub-456137
DOI to cite this document:
10.5283/epub.45613
Fisser, Christoph ; Winkler, Maren ; Malfertheiner, Maximilian Valentin ; Philipp, Alois ; Foltan, Maik ; Lunz, Dirk ; Zeman, Florian ; Maier, Lars S. ; Lubnow, Matthias ; Müller, Thomas
[img]
Preview
License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)
Date of publication of this fulltext: 10 Feb 2022 14:44


Abstract

Abstract Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct thrombin inhibitors are considered by some potentially advantageous over unfractionated heparin (UFH). We tested the hypothesis that Argatroban is non-inferior to UFH regarding thrombosis and bleeding during vvECMO. Methods We conducted a propensity-score matched observational non-inferiority study ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -5707

Contact persons